• Profile
Close
Sign Up / Log In
Journal Summaries
Family Medicine
  Choose Topic

Myasthenia Gravis Impairment Index: Responsiveness, meaningful change, and relative efficiency

Neurology® | Nov 10, 2017 Neurology General Family Medicine

Sunscreen formulations do not interfere with sweat cooling during exercise

International Journal of Cosmetic Science | Nov 10, 2017 General Family Medicine Dermatology Women`s Health

Single-dose gene-replacement therapy for spinal muscular atrophy

New England Journal of Medicine | Nov 09, 2017 General Family Medicine Neurology

Percutaneous coronary intervention in stable angina (ORBITA): A double-blind, randomised controlled trial

The Lancet | Nov 09, 2017 General Family Medicine Cardiology

Long-term safety and efficacy of reslizumab in patients with eosinophilic asthma

The Journal of Allergy and Clinical Immunology: In Practice | Nov 09, 2017 General Family Medicine Allergy/Immunology Clinical Pharmacology

Malignant neoplasms in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors, tocilizumab, abatacept, or rituximab in clinical practice: A nationwide cohort study from Sweden

JAMA Internal Medicine | Nov 09, 2017 General Family Medicine Clinical Pharmacology Orthopedic/Physical Med

Association of thyroid function with life expectancy with and without cardiovascular disease: The Rotterdam study

JAMA Internal Medicine | Nov 09, 2017 General Family Medicine Preventive/Nutrition Endocrinology Cardiology

Retreatment with sofosbuvir plus grazoprevir/elbasvir plus ribavirin of patients with hepatitis C virus genotype 1 or 4 who previously failed a NS5A or NS3-containing regimen. ANRS HC34 REVENGE

Clinical Infectious Diseases | Nov 09, 2017 General Family Medicine Clinical Pharmacology Infectious Disease

Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children

Clinical Infectious Diseases | Nov 09, 2017 General Family Medicine Obstetrics

Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles

Annals of Rheumatic Diseases | Nov 09, 2017 Clinical Pharmacology Allergy/Immunology General Family Medicine

1 … 1816 1818 1820 … 2433
Most read this week
Bannerimg

A variety of information related to Medicine and Health Care. It's all here.

Select Topic

x
M3 app logo
Choose easy access to M3 India from your mobile!

Add to home

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay